| 000 | 01591 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250514205540.0 | ||
| 264 | 0 | _c20051004 | |
| 008 | 200510s 0 0 eng d | ||
| 022 | _a1536-4828 | ||
| 024 | 7 |
_a10.1097/00006676-200411000-00004 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWang, Xing-Peng | |
| 245 | 0 | 0 |
_aAngiotensin II mediates acinar cell apoptosis during the development of rat pancreatic fibrosis by AT1R. _h[electronic resource] |
| 260 |
_bPancreas _cNov 2004 |
||
| 300 |
_a264-70 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAngiotensin II _xmetabolism |
| 650 | 0 | 4 |
_aAngiotensin II Type 1 Receptor Blockers _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aApoptosis _xgenetics |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aFibrosis _xchemically induced |
| 650 | 0 | 4 |
_aGene Expression Regulation _xgenetics |
| 650 | 0 | 4 |
_aIn Situ Nick-End Labeling _xmethods |
| 650 | 0 | 4 |
_aLosartan _xpharmacology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPancreas _xchemistry |
| 650 | 0 | 4 |
_aPancreatic Ducts _xdrug effects |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aReceptor, Angiotensin, Type 1 _xmetabolism |
| 650 | 0 | 4 |
_aReverse Transcriptase Polymerase Chain Reaction _xmethods |
| 650 | 0 | 4 |
_aTrinitrobenzenesulfonic Acid _xadverse effects |
| 700 | 1 | _aZhang, Ruling | |
| 700 | 1 | _aWu, Kai | |
| 700 | 1 | _aWu, Liying | |
| 700 | 1 | _aDong, Yuwei | |
| 773 | 0 |
_tPancreas _gvol. 29 _gno. 4 _gp. 264-70 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00006676-200411000-00004 _zAvailable from publisher's website |
| 999 |
_c15191834 _d15191834 |
||